Kristin Bolinger, DO
Family Medicine · Des Moines, IANPI 1619105186
Payments from drug & device makers
Across 29 payments — averaging $18.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$102
- Merck$65
- Pfizer$64
- Novo Nordisk$49
- Biogen$47
- Johnson & Johnson$44
- plus $176 from 7 others
What the payments were for
- Food & beverage$547100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $102 |
| Merck | 4 | $65 |
| Pfizer | 4 | $64 |
| Novo Nordisk | 3 | $49 |
| Biogen | 2 | $47 |
| Johnson & Johnson | 3 | $44 |
| Abiomed | 1 | $43 |
| AstraZeneca(2 entities) | 2 | $40 |
| Abbott | 1 | $24 |
| Sanofi-aventis U.S. LLC | 1 | $21 |
| Xeris Pharmaceuticals, Inc. | 1 | $19 |
| Hologic Sales And Service, LLC | 1 | $17 |
| GSK | 1 | $14 |
How this compares
$547 in reported general payments places this provider in the 70th percentile of 1,357 family medicine providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Topiramate | 14 | $465 |
| Oxybutynin Chloride ErOxybutynin Chloride | 23 | $455 |
| Phenytoin Sodium Extended | 13 | $372 |
| Meclizine Hcl | 13 | $282 |
| Potassium Chloride | 19 | $269 |
| Gabapentin | 21 | $258 |
| Atorvastatin Calcium | 43 | $177 |
| Metoprolol Succinate | 17 | $142 |
| Levothyroxine Sodium | 20 | $126 |
| Omeprazole | 14 | $112 |
| Amlodipine Besylate | 15 | $72 |
| Citalopram HbrCitalopram Hydrobromide | 12 | $69 |
| Simvastatin | 11 | $56 |
| Lisinopril | 14 | $56 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Des Moines
- Thomas RossDes Moines$170K
- Yogesh ShahDes Moines$159K
- Dylan LoweDes Moines$105K
- Lisa KlockDes Moines$9K
- Kristin GisselmanDes Moines$8K
- Nicholas GoetschWaterloo$4.1M
- James PoockWaterloo$1.5M
- Jennifer KayCouncil Bluffs$613K
- Nicholas BechtoldSioux City$584K
- Kirk PetersonHuxley$576K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.